Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study

• Main Authors: Roze Isono-Taniguchi (Author), Mayako Goto (Author), Yumi Takimoto (Author), Tomoko Ueda (Author), Yu Wakimoto (Author), Kayo Inoue (Author), Kensuke Hori (Author), Kimihiko Ito (Author), Hiroshi Tsubamoto (Author)
• Format: Book
• Published: Elsevier, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

No standard chemotherapy is available after disease progression or anaphylaxis during platinum chemotherapy among patients with recurrent cervical cancer. Here we report the efficacy and toxicities of metronomic chemotherapy consisting of 50 mg of oral cyclophosphamide (CPA) daily and intravenous 15...